APAC Urothelial Carcinoma Market, Market Segmented, by Diagnosis (Cystoscopy, Biopsy, Urinalysis, Urine Cytology, Intravenous Pyelogram (IVP), and Others), By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, and Other)- Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138350
- Pages: 200
-
Format:
Report Overview
The APAC Urothelial Carcinoma Market, market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 9.4% during the forecast period
In most of the types, all bladdercancers (8090%) start in theurothelialcells lining thebladderwall. This is sometimes calledtransitional cell carcinoma.Urothelial carcinomacan be papillary or flat (below), and can sometimes occur in the ureters and kidneys
Market Drivers
The rising healthcare industry, majorly in the emerging economies of the region such as India and China, is significantly propelling the growth of the market in Asia-Pacific. A growing number of smokers in Asian economies is one of the major factors attributing to an increasing number of bladder cancer patients. The number of smokers is increasing substantially in the adult population of the region due to changing lifestyles and shifting habits towards smoking and tobacco consumption. Other factors that are considered as a significant cause of bladder cancer include radiation exposure, intake, or exposure to harmful chemicals, aging, and others
1. APAC Urothelial Carcinoma Market Overview
A. Market Size
2. APAC Urothelial Carcinoma Growth Drivers
A. The rising healthcare industry, majorly in the emerging economies of the region such as India and China
B. The number of smokers is increasing substantially in the adult population of the region
C. Factors that are considered as a significant cause of bladder cancer include radiation exposure, intake, or exposure to harmful chemicals, aging, and others
3. APAC Urothelial Carcinoma Market Segmentation
A. By Diagnosis
I. Cystoscopy
II. Biopsy
III. Urinalysis
IV. Urine Cytology
V. Intravenous Pyelogram (IVP)
VI. Others
B. By Surgery
I. Chemotherapy
II. Immunotherapy
III. Radiation Therapy
IV. Surgery
V. Other
4. Urothelial Carcinoma Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Sanofi S.A, Company overview, Product & Services, Strategies & Financials
B. Pfizer, Inc., Company overview, Product & Services, Strategies & Financials
C. F. Hoffmann-La Roche, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
